Stockscreener 앱 받기
66.96
2.87%
-1.98
시장 영업 전:
67.03
0.07
+0.10%
전일 마감가:
$68.94
열려 있는:
$69.025
하루 거래량:
6.85M
Relative Volume:
1.06
시가총액:
$26.12B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
46.87
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
+2.24%
1개월 성능:
+12.33%
6개월 성능:
-19.18%
1년 성능:
-15.17%
1일 변동 폭
$66.67
$69.31
1주일 범위
$64.00
$69.77
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
66.96 | 26.89B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein - GlobeNewswire
Shareholders of DexCom, Inc. (DXCM): Protect Your Rights Before December 26, 2025Contact Levi & Korsinsky - Stockhouse
DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit - PR Newswire
Castleark Management LLC Invests $27.18 Million in DexCom, Inc. $DXCM - Defense World
2025-12-13 | Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Class Action Lawsuit and December 26, 2025 Deadline | NDAQ:DXCM | Press Release - Stockhouse
DXCM DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM - GlobeNewswire Inc.
Jim Cramer on DexCom: "It's Too Rich a Stock" - Finviz
Jim Cramer on DexCom: “It’s too rich a stock” - MSN
Jim Cramer on DexCom: “It’s Too Rich a Stock” - Insider Monkey
Bellevue Group AG Cuts Holdings in DexCom, Inc. $DXCM - MarketBeat
Shareholders of DexCom, Inc. Should Contact Levi & - GlobeNewswire
Key facts: DexCom faces class action lawsuit; Citigroup raises price target - TradingView — Track All Markets
DexCom, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Business Wire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SueWallSt Podcast Explains Class Action Against DexCom, Inc. (DXCM) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Citigroup Maintains DexCom (DXCM) Buy Recommendation - Nasdaq
DexCom Stock Surges 12%, With A 11-Day Winning Spree - Trefis
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom (DXCM) Sees Buy Rating Maintained by Citigroup with Price - GuruFocus
Your Guide to the DexCom, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. LawsuitDXCM - PR Newswire
Citigroup Adjusts DexCom Price Target to $77 From $75, Maintains Buy Rating - marketscreener.com
Frontier Capital Management Co. LLC Sells 35,907 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom Stock 10-Day Winning Spree: Stock Climbs 9.5% - Trefis
DXCM Deadline: DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - marketscreener.com
Levi & Korsinsky Releases SueWallSt Podcast on DexCom, Inc. (DXCM) Lawsuit - ACCESS Newswire
Sirios Capital Management L P Boosts Stock Position in DexCom, Inc. $DXCM - MarketBeat
Natixis Has $5.47 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by California Public Employees Retirement System - MarketBeat
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
DexCom Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases Shares of 33,470 DexCom, Inc. $DXCM - MarketBeat
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bank of Nova Scotia Sells 400,824 Shares of DexCom, Inc. $DXCM - MarketBeat
2Xideas AG Sells 27,564 Shares of DexCom, Inc. $DXCM - MarketBeat
8-Day Rally Sends DexCom Stock Up 6.4% - Trefis
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to - GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - WV News
DexCom, Inc. $DXCM Shares Acquired by WINTON GROUP Ltd - MarketBeat
Thematics Asset Management Boosts Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Holdings Decreased by Brown Advisory Inc. - Defense World
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky to Join Class Action Before December 26, 2025 - Stockhouse
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.44%
0.52%
자본화:
|
볼륨(24시간):